They claimed there were widespread rumour in social media that delegations of a few countries with little or no experience on the topic were driving an agenda at the global tobacco control conference here to prohibit electronic nicotine delivery system (ENDS) or e-cigarette.
The experts, who have long advocated for evidence-based regulations on electronic nicotine delivery system (ENDS) or e-cigarette, said there is a clear public health benefit from having access to high-quality, appropriately regulated ENDS product.
"There is a clear public health benefit from having access to high-quality, appropriately regulated ENDS product," they said in a statement.
The experts, including Julian Morris of Reason Foundation, Konstantinos Farsalinos, Riccardo Polosa and Christopher Russell, said, "Such a course of action would be a huge mistake and do untold harm to millions of smokers. We hope these rumours are untrue and do not reflect the current climate and the real intentions of WHO COP7 delegates."
India is hosting the Seventh Session of the Conference of Parties (COP7) to World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) for the first time.
Meanwhile, health experts in India have said that for e-cigarette to become a "promising alternative" nicotine replacement therapy, there is a need for further research on its long-term health effects and putting in place regulations to limit its sale to adults only.
M Siddiqi, the chairman of the Cancer Foundation of India in Kolkata, and R N Sharan, Professor of Biochemistry at North-Eastern Hill University, Shillong, had recently written to Health Minister J P Nadda regarding the issue.
"We, believe that ENDS to become a promising alternative NRT, there is an immediate need of further research on its long-term health effects. Furthermore, regulation should be put in place for quality controls and limiting its sale to adults only," they had said in the letter.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
